Neuraxis to host first quarter 2024 results and business update call on wednesday, may 22, 2024

Carmel, ind., may 15, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its first quarter 2024, for the period ended march 31, 2024, on wednesday, may 22, 2024, before market open. the company has scheduled a conference call for the same day, wednesday, may 22, 2024, at 9:00 am et to review the results.
NRXS Ratings Summary
NRXS Quant Ranking